KeyGene Webinar: Apomixis: the breakthrough breeding technology for the 2020s
On Thursday, February 17, 2022, 15:30-17:00 CET, KeyGene will organize an international webinar on the new possibilities for applying apomixis in crop breeding. The webinar will be featuring scientists and breeders from Italy, Ireland, Germany, Canada, and the Netherlands. Participation is free.
The reason for this webinar is the paper in Nature Genetics of 6 January 2022 about the identification of the PAR gene, by an international team of scientists from KeyGene, Wageningen University & Research, the Japanese breeding company Takii and New Zealand’s Plant & Food Research, and Lincoln University.
The identification of the PAR gene, together with the DIP gene, earlier described by KeyGene scientists, will hopefully be the starting point for the successful application of apomixis in many important crops during the next decade.
During this KeyGene webinar, Peter van Dijk will present and discuss the findings of the international team, published in Nature Genetics on 6 January 2022. Other apomixis and plant reproduction experts from science and breeding will present their work and views
After the presentations, questions from the audience will be asked and an international panel, together with the speakers and moderated by KeyGene’s CEO Arjen van Tunen, will discuss questions like limiting factors, crops within reach, and the possibilities for inducing and identifying the needed genotypes.
- Reproduction of plants: an exciting field of research and opportunities, Lucia Colombo, University of Milan (also known as La Statale), Italy
- Booster for apomixis: PAR and DIP genes, Rik Op den Camp, KeyGene
- Boecher’s rockcress: an apomictic model species for the application of apomixis in canola and other Brassica crops, Prof. Tim Sharbel, Department of Plant Sciences, University of Saskatchewan, Canada
- Panel discussion, moderated by Arjen van Tunen. Panel members: Charles Spillane, National University of Ireland Galway, Eric Schranz, Wageningen University & Research; Peter van Dijk, KeyGene; Charles Underwood, Max Planck Institute